Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
Ambrx Biopharma Debt to Equity Ratio: 0.00 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | |
| June 30, 2022 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2022
--
Maximum
Jun 2022
--
Average
--
Median
Jun 2022
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5096 |
| Axonics Inc | 0.00 |
| Harpoon Therapeutics Inc (DELISTED) | 0.00 |
| Merck & Co Inc | 0.8568 |
| RayzeBio inc (DELISTED) | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 271.50M |
| Total Liabilities (Quarterly) | 29.10M |
| Shareholders Equity (Quarterly) | 242.40M |
| Current Ratio | 12.80 |